Company Quick10K Filing
NCL
10-Q 2020-03-31 Filed 2020-05-15
10-K 2019-12-31 Filed 2020-02-27
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-02-27
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-02-27
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-09
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-02-29
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-02-27
10-Q 2014-09-30 Filed 2014-10-31
10-Q 2014-06-30 Filed 2014-07-31
10-Q 2014-03-31 Filed 2014-05-01
10-K 2013-12-31 Filed 2014-02-21
10-Q 2013-09-30 Filed 2013-10-31
10-Q 2013-06-30 Filed 2013-07-30
10-Q 2013-03-31 Filed 2013-05-08
10-K 2012-12-31 Filed 2013-02-20
20-F 2011-12-31 Filed 2012-02-22
20-F 2010-12-31 Filed 2011-02-09
20-F 2009-12-31 Filed 2010-02-24
8-K 2020-06-19
8-K 2020-06-04
8-K 2020-06-03
8-K 2020-05-28
8-K 2020-05-14
8-K 2020-05-14
8-K 2020-05-05
8-K 2020-05-05
8-K 2020-05-05
8-K 2020-05-05
8-K 2020-04-28
8-K 2020-04-27
8-K 2020-04-20
8-K 2020-03-12
8-K 2020-03-05
8-K 2020-02-20
8-K 2019-12-16
8-K 2019-12-02
8-K 2019-11-29
8-K 2019-11-07
8-K 2019-10-03
8-K 2019-08-08
8-K 2019-06-07
8-K 2019-05-15
8-K 2019-05-09
8-K 2019-02-21
8-K 2019-01-10
8-K 2019-01-08
8-K 2019-01-02
8-K 2018-11-28
8-K 2018-11-28
8-K 2018-11-08
8-K 2018-09-11
8-K 2018-08-09
8-K 2018-07-18
8-K 2018-07-11
8-K 2018-05-02
8-K 2018-04-23
8-K 2018-04-17
8-K 2018-03-20
8-K 2018-03-05
8-K 2018-02-27
8-K 2018-02-27
8-K 2018-02-22
8-K 2018-01-30

NCL Financials

NCLC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Capital Properties (CPTP) 97 0% 30.3 23% 10 2 4 0 2 3 95
Processa Pharmaceuticals (PCSA) 97 -40.0 -24% 11 2 0 0 -3 -2 96
Addentax Group (ATXG) 96 14% -113.5 -15% 6 8 9 1 -1 -1 96
Eaco (EACO) 96 28% 6.2 10% 89 40 216 60 9 15 93
Cortland Bancorp (CLDB) 95 7.1 1% 701 626 0 0 5 11 75
ChoiceOne Financial Services (COFS) 95 0% 8.1 1% 664 579 4 0 6 10 78
Aerkomm (AKOM) 94 1% -11.7 -17% 51 4 2 0 -9 -8 92
Invuity (IVTY) 93 67% -2.9 -75% 49 46 41 27 -36 -32 93
First National (FXNC) 92 0% 5.0 1% 777 702 6 0 7 12 62
Nobility Homes (NOBH) 92 28% 9.0 11% 56 8 36 10 6 8 71
NCL (NCLC) 91 0% 4.3 6% 15,932 9,700 6,385 0 974 1,433 6,107
Cannapharmarx (CPMD) 90 -12.2 -50% 22 10 0 0 -11 -8 97
Humanigen (HGEN) 90 -12.4 -1,392% 1 13 0 0 -8 -7 90
Mattersight (MATR) 89 72% -20.5 -39% 29 33 50 36 -11 -5 93
Farmers & Merchants Bancshares (FMFG) 89 7.8 1% 435 386 0 0 5 9 69
Fuse Medical (FZMD) 88 42% -23.1 -26% 18 21 16 7 -5 -4 87
Tropic International (TRPO) 86 -98.1 -69% 1 4 0 0 -1 -1 86
Anvia Holdings (ANVV) 86 51% -26.9 -22% 15 13 10 5 -3 -3 86
Liberated Syndication (LSYN) 86 86% 13.7 7% 43 13 18 16 3 6 77
Community Bancorp (CMTV) 84 5.3 1% 729 662 0 0 9 16 84

Balance Sheet ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6676535261635583119171217113135140153126218217520171299203279162302416401
Accounts Receivable131618181827263231374245456055634850574441444655577568
Inventory424546444853515757605558626866667177798280939690909194
PP&E4,9985,6025,6237,1146,3276,3056,32010,3498,6298,6758,72411,5029,48910,06810,05412,56110,14910,97410,91713,92211,08612,08612,02915,52512,18112,25212,289
Assets5,9756,5816,6016,6217,2897,2927,35511,55111,56711,66211,71212,24012,36312,93012,91912,95113,05313,92414,24314,07014,48115,32715,30715,20515,75715,96215,932
Accounts Payable6897998780103100102855544515446513871474553665559160677672
Long-Term Debt2,7483,0933,1053,1463,7773,6263,5716,2296,0255,8125,7666,4966,4006,7006,5006,5266,2946,8646,7966,4496,4586,9656,6946,6026,6866,4716,417
Liabilities3,5844,2064,0283,9894,6274,5844,4698,0328,1377,9717,8438,4978,4898,8628,4338,4638,4868,9918,7838,4028,9029,6929,1639,2879,8989,8549,700
Stockholders' Equity2,3912,3752,5742,6322,6622,7082,8863,5193,4303,6913,8693,7433,8754,0684,4864,4884,5674,9335,4595,6695,5805,6366,1455,9185,8606,1086,231
Income Statement ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue5286447986006647669077899381,0851,2851,0371,0781,1871,4851,1251,1511,3441,6521,2501,2931,5221,8581,3811,4041,6871,914
Cost of Revenue363421456418446471
Gross Profit165223342183218295
R&D
SG&A85737863818296139154106150142180149174160192193202185226226234248240255
Tax22-46-00-00002-31512-3236-3447
Net Income-95-71814043115210-29-201622564075148346756320139698105230475156119243455
Cash Flow ($MM)2013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating7918015078230179-6835135028171334419342158436488443228613469540529424
Cash Investing-85-674-77-59-746-77-1,014-59-128-145-875-133-666-151-179-118-983-64-240-144-110-222-206-217
Cash Financing26505-96-20526-1101,110-256-170-90700-179252-178-6-226494-76-338-341-283-179-208-223